COMMENTARY ON THE LAW
Phospholipids and products of their hydrolysis as dietary preventive factors for civilization diseases
Karol Parchem 1 , Agnieszka Bartoszek 11. Katedra Chemii, Technologii i Biotechnologii Żywności, Wydział Chemiczny, Politechnika Gdańska
Published: 2016-12-31
DOI: 10.5604/17322693.1227640
GICID: 01.3001.0009.6911
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2016; 70 : 1343-1361
Abstract
The results of numerous epidemiological studies indicate that phospholipids play an important role in the prevention of chronic diseases faced by contemporary society. Firstly, these compounds are responsible for the proper functioning of cell membranes, by ensuring liquidity and permeability, which is pivotal for normal activity of membrane proteins, including receptors. These mechanisms are at the core of prevention of cancer, autoimmune or neurological disorders. Secondly, structure and properties of phospholipids cause that they are highly available source of biologically active fatty acids. Thirdly, also products of endogenous hydrolysis of phospholipids exhibit biological activity. These include lysophospholipids formed as a result of disconnecting free fatty acid from glycerophospholipids in the reaction catalyzed by phospholipase A, phosphatidic acid and hydrophilic subunits released by the activity of phospholipase D. The bioactive products of hydrolysis also include ceramides liberated from phosphosphingolipids after removal of a hydrophilic unit catalyzed by sphingomyelinase. Phospholipids are supplied to the human body with food. A high content of phospholipids is characteristic for egg yolk, liver, pork and poultry, as well as some soy products. Particularly beneficial are phospholipids derived from seafood because they are a rich source of essential fatty acids of the n-3 family.
References
- 1. Adachi M., Horiuchi G., Ikematsu N., Tanaka T., Terao J., SatouchiK., Tokumura A.: Intragastrically administered lysophosphatidicacids protect against gastric ulcer in rats under water-immersionrestraint stress. Dig. Dis. Sci., 2011; 56: 2252-2261
Google Scholar - 1. Adachi M., Horiuchi G., Ikematsu N., Tanaka T., Terao J., SatouchiK., Tokumura A.: Intragastrically administered lysophosphatidicacids protect against gastric ulcer in rats under water-immersionrestraint stress. Dig. Dis. Sci., 2011; 56: 2252-2261
Google Scholar - 2. An S., Goetzl E.J., Lee H.: Signaling mechanisms and molecularcharacteristics of G protein‐coupled receptors for lysophosphatidicacid and sphingosine 1‐phosphate. J. Cell. Bioch. Suppl., 1998; 72(Suppl. 30/31): 147-157
Google Scholar - 2. An S., Goetzl E.J., Lee H.: Signaling mechanisms and molecularcharacteristics of G protein‐coupled receptors for lysophosphatidicacid and sphingosine 1‐phosphate. J. Cell. Bioch. Suppl., 1998; 72(Suppl. 30/31): 147-157
Google Scholar - 3. Bazan N.G.: Neuroprotectin D1 (NPD1): A DHA‐derived mediatorthat protects brain and retina against cell injury‐induced oxidativestress. Brain Pathol., 2005; 15: 159-166
Google Scholar - 3. Bazan N.G.: Neuroprotectin D1 (NPD1): A DHA‐derived mediatorthat protects brain and retina against cell injury‐induced oxidativestress. Brain Pathol., 2005; 15: 159-166
Google Scholar - 4. Burgess J.W., Neville T.A., Rouillard P., Harder Z., Beanlands D.S.,Sparks D.L.: Phosphatidylinositol increases HDL-C levels in humans.J. Lipid Res., 2005; 46: 350-355
Google Scholar - 4. Burgess J.W., Neville T.A., Rouillard P., Harder Z., Beanlands D.S.,Sparks D.L.: Phosphatidylinositol increases HDL-C levels in humans.J. Lipid Res., 2005; 46: 350-355
Google Scholar - 5. Calder P.C.: The role of marine omega‐3 (n‐3) fatty acids in inflammatoryprocesses, atherosclerosis and plaque stability. Mol.Nutr. Food Res., 2012; 56: 1073-1080
Google Scholar - 5. Calder P.C.: The role of marine omega‐3 (n‐3) fatty acids in inflammatoryprocesses, atherosclerosis and plaque stability. Mol.Nutr. Food Res., 2012; 56: 1073-1080
Google Scholar - 6. Caterina r., Basta G.: n-3 Fatty acids and the inflammatory response– biological background. Eur. Heart J. Suppl., 2001; 3 (Suppl.D): D42-D49
Google Scholar - 6. Caterina r., Basta G.: n-3 Fatty acids and the inflammatory response– biological background. Eur. Heart J. Suppl., 2001; 3 (Suppl.D): D42-D49
Google Scholar - 7. Christie W.: Ether Lipids, http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39320 (06.12.2015)
Google Scholar - 7. Christie W.: Ether Lipids, http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39320 (06.12.2015)
Google Scholar - 8. Christie W.: Long-Chain or Sphingoid Bases, http://lipidlibrary.aocs.org/content.cfm?ItemNumber=39337 (06.12.2015)
Google Scholar - 8. Christie W.: Long-Chain or Sphingoid Bases, http://lipidlibrary.aocs.org/content.cfm?ItemNumber=39337 (06.12.2015)
Google Scholar - 9. Christie W.: Phosphonolipids, http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39356(05.02.2016)
Google Scholar - 9. Christie W.: Phosphonolipids, http://lipidlibrary.aocs.org/Primer/content.cfm?ItemNumber=39356(05.02.2016)
Google Scholar - 10. Chrousos G.P.: Stress and disorders of the stress system. Nat.Rev. Endocrinol., 2009; 5: 374-381
Google Scholar - 10. Chrousos G.P.: Stress and disorders of the stress system. Nat.Rev. Endocrinol., 2009; 5: 374-381
Google Scholar - 11. Cohn J.S., Kamili A., Wat E., Chung r.W., Tandy S.: Dietary phospholipidsand intestinal cholesterol absorption. Nutrients, 2010;2: 116-127
Google Scholar - 11. Cohn J.S., Kamili A., Wat E., Chung r.W., Tandy S.: Dietary phospholipidsand intestinal cholesterol absorption. Nutrients, 2010;2: 116-127
Google Scholar - 12. Cohn J.S., Wat E., Kamili A., Tandy S.: Dietary phospholipids,hepatic lipid metabolism and cardiovascular disease. Curr. Opin.Lipidol., 2008; 19: 257-262
Google Scholar - 12. Cohn J.S., Wat E., Kamili A., Tandy S.: Dietary phospholipids,hepatic lipid metabolism and cardiovascular disease. Curr. Opin.Lipidol., 2008; 19: 257-262
Google Scholar - 13. Cole B.F., Logan r.F., Halabi S., Benamouzig r., Sandler r.S.,Grainge M.J., Chaussade S., Baron J.A.: Aspirin for the chemopreventionof colorectal adenomas: meta-analysis of the randomizedtrials. J. Natl. Cancer Inst., 2009; 101: 256-266
Google Scholar - 13. Cole B.F., Logan r.F., Halabi S., Benamouzig r., Sandler r.S.,Grainge M.J., Chaussade S., Baron J.A.: Aspirin for the chemopreventionof colorectal adenomas: meta-analysis of the randomizedtrials. J. Natl. Cancer Inst., 2009; 101: 256-266
Google Scholar - 14. Cole G.M., Ma Q.L., Frautschy S.A.: Omega-3 fatty acids and dementia.Prostaglandins Leukot. Essent. Fatty Acids, 2009; 81: 213-221
Google Scholar - 14. Cole G.M., Ma Q.L., Frautschy S.A.: Omega-3 fatty acids and dementia.Prostaglandins Leukot. Essent. Fatty Acids, 2009; 81: 213-221
Google Scholar - 15. Corsetto P.A., Montorfano G., Zava S., Jovenitti I.E., CremonaA., Berra B., Rizzo A.M.: Effects of n-3 PUFAs on breast cancer cellsthrough their incorporation in plasma membrane. Lipids HealthDis., 2011; 10: 73
Google Scholar - 15. Corsetto P.A., Montorfano G., Zava S., Jovenitti I.E., CremonaA., Berra B., Rizzo A.M.: Effects of n-3 PUFAs on breast cancer cellsthrough their incorporation in plasma membrane. Lipids HealthDis., 2011; 10: 73
Google Scholar - 16. Cryer B., Bhatt D.L., Lanza F.L., Dong J.F., Lichtenberger L.M.,Marathi U.K.: Low-dose aspirin-induced ulceration is attenuatedby aspirin-phosphatidylcholine: a randomized clinical trial. Am. J.Gastroenterol., 2011; 106: 272-277
Google Scholar - 16. Cryer B., Bhatt D.L., Lanza F.L., Dong J.F., Lichtenberger L.M.,Marathi U.K.: Low-dose aspirin-induced ulceration is attenuatedby aspirin-phosphatidylcholine: a randomized clinical trial. Am. J.Gastroenterol., 2011; 106: 272-277
Google Scholar - 17. Darlington L.G., Stone T.W.: Antioxidants and fatty acids in theamelioration of rheumatoid arthritis and related disorders. Br. J.Nutr., 2001; 85: 251-269
Google Scholar - 17. Darlington L.G., Stone T.W.: Antioxidants and fatty acids in theamelioration of rheumatoid arthritis and related disorders. Br. J.Nutr., 2001; 85: 251-269
Google Scholar - 18. Das S.K., Hiran K.R., Mukherjee S., Vasudevan D.M.: Oxidativestress is the primary event: effects of ethanol consumption in brain.Indian J. Clin. Biochem., 2007; 22: 99-104
Google Scholar - 18. Das S.K., Hiran K.R., Mukherjee S., Vasudevan D.M.: Oxidativestress is the primary event: effects of ethanol consumption in brain.Indian J. Clin. Biochem., 2007; 22: 99-104
Google Scholar - 19. Deng W., Balazs L., Wang D.A., Van Middlesworth L., Tigyi G.,Johnson L.R.: Lysophosphatidic acid protects and rescues intestinalepithelial cells from radiation-and chemotherapy-induced apoptosis.Gastroenterology, 2002; 123: 206-216
Google Scholar - 19. Deng W., Balazs L., Wang D.A., Van Middlesworth L., Tigyi G.,Johnson L.R.: Lysophosphatidic acid protects and rescues intestinalepithelial cells from radiation-and chemotherapy-induced apoptosis.Gastroenterology, 2002; 123: 206-216
Google Scholar - 20. Dennis E.A.: Lipidomics joins the omics evolution. Proc. Natl.Acad. Sci. USA, 2009; 106: 2089-2090
Google Scholar - 20. Dennis E.A.: Lipidomics joins the omics evolution. Proc. Natl.Acad. Sci. USA, 2009; 106: 2089-2090
Google Scholar - 21. Dumitru C.A., Sandalcioglu I.E., Wagner M., Weller M., Gulbins E.:Lysosomal ceramide mediates gemcitabine-induced death of gliomacells. J. Mol. Med., 2009; 87: 1123-1132
Google Scholar - 21. Dumitru C.A., Sandalcioglu I.E., Wagner M., Weller M., Gulbins E.:Lysosomal ceramide mediates gemcitabine-induced death of gliomacells. J. Mol. Med., 2009; 87: 1123-1132
Google Scholar - 22. Eckhardt E.R., Wang D.Q., Donovan J.M., Carey M.C.: Dietarysphingomyelin suppresses intestinal cholesterol absorption by decreasingthermodynamic activity of cholesterol monomers. Gastroenterology,2002; 122: 948-956
Google Scholar - 22. Eckhardt E.R., Wang D.Q., Donovan J.M., Carey M.C.: Dietarysphingomyelin suppresses intestinal cholesterol absorption by decreasingthermodynamic activity of cholesterol monomers. Gastroenterology,2002; 122: 948-956
Google Scholar - 23. Etminan M., Gill S., Samii A.: Effect of non-steroidal anti-inflammatorydrugs on risk of Alzheimer’s disease: systematic review andmeta-analysis of observational studies. Br. Med. J., 2003; 327: 128
Google Scholar - 23. Etminan M., Gill S., Samii A.: Effect of non-steroidal anti-inflammatorydrugs on risk of Alzheimer’s disease: systematic review andmeta-analysis of observational studies. Br. Med. J., 2003; 327: 128
Google Scholar - 24. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill A.H.Jr.,Murphy r.C., Raetz C.R., Russell D.W., Seyama Y., Shaw W., Shimizu T.,Spener F., van Meer G., VanNieuwenhze M.S., White S.H., WitztumJ.L., Dennis E.A.: A comprehensive classification system for lipids. J.Lipid Res., 2005; 46: 839-861
Google Scholar - 24. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill A.H.Jr.,Murphy r.C., Raetz C.R., Russell D.W., Seyama Y., Shaw W., Shimizu T.,Spener F., van Meer G., VanNieuwenhze M.S., White S.H., WitztumJ.L., Dennis E.A.: A comprehensive classification system for lipids. J.Lipid Res., 2005; 46: 839-861
Google Scholar - 25. Fahy E., Subramaniam S., Murphy r.C., Nishijima M., Raetz C.R.,Shimizu T., Spener F., van Meer G., Wakelam M.J., Dennis E.A.: Updateof the LIPID MAPS comprehensive classification system for lipids. J.Lipid Res., 2009; 50 (Supplement): S9-S14
Google Scholar - 25. Fahy E., Subramaniam S., Murphy r.C., Nishijima M., Raetz C.R.,Shimizu T., Spener F., van Meer G., Wakelam M.J., Dennis E.A.: Updateof the LIPID MAPS comprehensive classification system for lipids. J.Lipid Res., 2009; 50 (Supplement): S9-S14
Google Scholar - 26. Frankel A., Mills G.B.: Peptide and lipid growth factors decreasecis-diamminedichloroplatinum-induced cell death in human ovariancancer cells. Clin. Cancer Res., 1996; 2: 1307-1313
Google Scholar - 26. Frankel A., Mills G.B.: Peptide and lipid growth factors decreasecis-diamminedichloroplatinum-induced cell death in human ovariancancer cells. Clin. Cancer Res., 1996; 2: 1307-1313
Google Scholar - 27. Goyens P.L., Spilker M.E., Zock P.L., Katan M.B., Mensink r.P.:Compartmental modeling to quantify α-linolenic acid conversionafter longer term intake of multiple tracer boluses. J. Lipid Res.,2005; 46: 1474-1483
Google Scholar - 27. Goyens P.L., Spilker M.E., Zock P.L., Katan M.B., Mensink r.P.:Compartmental modeling to quantify α-linolenic acid conversionafter longer term intake of multiple tracer boluses. J. Lipid Res.,2005; 46: 1474-1483
Google Scholar - 28. Guo Z., Vikbjerg A.F., Xu X.: Enzymatic modification of phospholipidsfor functional applications and human nutrition. Biotechnol.Adv., 2005; 23: 203-259
Google Scholar - 28. Guo Z., Vikbjerg A.F., Xu X.: Enzymatic modification of phospholipidsfor functional applications and human nutrition. Biotechnol.Adv., 2005; 23: 203-259
Google Scholar - 29. Hellhammer J., Vogt D., Franz N., Freitas U., Rutenberg D.: A soybasedphosphatidylserine/phosphatidic acid complex (PAS) normalizesthe stress reactivity of hypothalamus-pituitary-adrenal-axis inchronically stressed male subjects: a randomized, placebo-controlledstudy. Lipids Health Dis., 2014; 13: 121
Google Scholar - 29. Hellhammer J., Vogt D., Franz N., Freitas U., Rutenberg D.: A soybasedphosphatidylserine/phosphatidic acid complex (PAS) normalizesthe stress reactivity of hypothalamus-pituitary-adrenal-axis inchronically stressed male subjects: a randomized, placebo-controlledstudy. Lipids Health Dis., 2014; 13: 121
Google Scholar - 30. Jäger r., Purpura M., Kingsley M.: Phospholipids and sports performance.J. Int. Soc. Sports Nutr., 2007; 4: 5
Google Scholar - 30. Jäger r., Purpura M., Kingsley M.: Phospholipids and sports performance.J. Int. Soc. Sports Nutr., 2007; 4: 5
Google Scholar - 31. Jayaraman T., Kannappan S., Ravichandran M.K., Anuradha C.V.:Impact of Essentiale L on ethanol-induced changes in rat brain anderythrocytes. Singapore Med. J., 2008; 49: 320-327
Google Scholar - 31. Jayaraman T., Kannappan S., Ravichandran M.K., Anuradha C.V.:Impact of Essentiale L on ethanol-induced changes in rat brain anderythrocytes. Singapore Med. J., 2008; 49: 320-327
Google Scholar - 32. Keller J.S.: Katabolizm tłuszczów. W: Żywienie człowieka: podstawynauki o żywieniu, red: J. Gawęcki, Wydawnictwo NaukowePWN, Warszawa 2010, 114-117
Google Scholar - 32. Keller J.S.: Katabolizm tłuszczów. W: Żywienie człowieka: podstawynauki o żywieniu, red: J. Gawęcki, Wydawnictwo NaukowePWN, Warszawa 2010, 114-117
Google Scholar - 33. Kingsley M.: Effects of phosphatidylserine supplementation onexercising humans. Sports Med., 2006; 36: 657-669
Google Scholar - 33. Kingsley M.: Effects of phosphatidylserine supplementation onexercising humans. Sports Med., 2006; 36: 657-669
Google Scholar - 34. Koo S.I., Noh S.K.: Phosphatidylcholine inhibits and lysophosphatidylcholineenhances the lymphatic absorption of α-tocopherolin adult rats. J. Nutr., 2001; 131: 717-722
Google Scholar - 34. Koo S.I., Noh S.K.: Phosphatidylcholine inhibits and lysophosphatidylcholineenhances the lymphatic absorption of α-tocopherolin adult rats. J. Nutr., 2001; 131: 717-722
Google Scholar - 35. Küllenberg D., Taylor L.A., Schneider M., Massing U.: Health effectsof dietary phospholipids. Lipids Health Dis., 2012; 11: 3
Google Scholar - 35. Küllenberg D., Taylor L.A., Schneider M., Massing U.: Health effectsof dietary phospholipids. Lipids Health Dis., 2012; 11: 3
Google Scholar - 36. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A.: Dietarylong-chain n-3 fatty acids for the prevention of cancer: a review ofpotential mechanisms. Am. J. Clin. Nutr., 2004; 79: 935-945
Google Scholar - 36. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A.: Dietarylong-chain n-3 fatty acids for the prevention of cancer: a review ofpotential mechanisms. Am. J. Clin. Nutr., 2004; 79: 935-945
Google Scholar - 37. Lee S.J., Yun C.C.: Colorectal cancer cells – proliferation, survivaland invasion by lysophosphatidic acid. Int. J. Biochem. CellBiol., 2010; 42; 1907-1910
Google Scholar - 37. Lee S.J., Yun C.C.: Colorectal cancer cells – proliferation, survivaland invasion by lysophosphatidic acid. Int. J. Biochem. CellBiol., 2010; 42; 1907-1910
Google Scholar - 38. Leszczyńska T., Pisulewski P.M.: Wpływ wybranych składnikówżywności na aktywność psychofizyczną człowieka. Żywn.-Nauk.Technol. Jak., 2004; 11: 12-24
Google Scholar - 38. Leszczyńska T., Pisulewski P.M.: Wpływ wybranych składnikówżywności na aktywność psychofizyczną człowieka. Żywn.-Nauk.Technol. Jak., 2004; 11: 12-24
Google Scholar - 39. Li Y.C., Park M.J., Ye S.K., Kim C.W., Kim Y.N.: Elevated levelsof cholesterol-rich lipid rafts in cancer cells are correlated withapoptosis sensitivity induced by cholesterol-depleting agents. Am.J. Pathol., 2006; 168: 1107-1118
Google Scholar - 39. Li Y.C., Park M.J., Ye S.K., Kim C.W., Kim Y.N.: Elevated levelsof cholesterol-rich lipid rafts in cancer cells are correlated withapoptosis sensitivity induced by cholesterol-depleting agents. Am.J. Pathol., 2006; 168: 1107-1118
Google Scholar - 40. Lichtenberger L.M., Barron M., Marathi U.: Association of phosphatidylcholineand NSAIDs as a novel strategy to reduce gastrointestinaltoxicity. Drugs Today, 2009; 45: 877-890
Google Scholar - 40. Lichtenberger L.M., Barron M., Marathi U.: Association of phosphatidylcholineand NSAIDs as a novel strategy to reduce gastrointestinaltoxicity. Drugs Today, 2009; 45: 877-890
Google Scholar - 41. Lichtenberger L.M., Romero J.J., Dial E.J.: Surface phospholipidsin gastric injury and protection when a selective cyclooxygenase‐2inhibitor (Coxib) is used in combination with aspirin. Br. J. Pharmacol.,2007; 150: 913-919
Google Scholar - 41. Lichtenberger L.M., Romero J.J., Dial E.J.: Surface phospholipidsin gastric injury and protection when a selective cyclooxygenase‐2inhibitor (Coxib) is used in combination with aspirin. Br. J. Pharmacol.,2007; 150: 913-919
Google Scholar - 42. Lieber C.S.: Alcoholic fatty liver: its pathogenesis and mechanismof progression to inflammation and fibrosis. Alcohol, 2004; 34: 9-19
Google Scholar - 42. Lieber C.S.: Alcoholic fatty liver: its pathogenesis and mechanismof progression to inflammation and fibrosis. Alcohol, 2004; 34: 9-19
Google Scholar - 43. Lieber C.S.: New concepts of the pathogenesis of alcoholic liverdisease lead to novel treatments. Curr. Gastroenterol. Rep., 2004;6: 60-65
Google Scholar - 43. Lieber C.S.: New concepts of the pathogenesis of alcoholic liverdisease lead to novel treatments. Curr. Gastroenterol. Rep., 2004;6: 60-65
Google Scholar - 44. Lieber C.S., Robins S.J., Leo M.A.: Hepatic phosphatidylethanolaminemethyltransferase activity is decreased by ethanol andincreased by phosphatidylcholine. Alcohol. Clin. Exp. Res., 1994;18: 592-595
Google Scholar - 44. Lieber C.S., Robins S.J., Leo M.A.: Hepatic phosphatidylethanolaminemethyltransferase activity is decreased by ethanol andincreased by phosphatidylcholine. Alcohol. Clin. Exp. Res., 1994;18: 592-595
Google Scholar - 45. Lieber C.S., Robins S.J., Li J., DeCarli L.M., Mak K.M., Fasulo J.M.,Leo M.A.: Phosphatidylcholine protects against fibrosis and cirrhosisin the baboon. Gastroenterology, 1994; 106: 152-159
Google Scholar - 45. Lieber C.S., Robins S.J., Li J., DeCarli L.M., Mak K.M., Fasulo J.M.,Leo M.A.: Phosphatidylcholine protects against fibrosis and cirrhosisin the baboon. Gastroenterology, 1994; 106: 152-159
Google Scholar - 46. Liscovitch M., Czarny M., Fiucci G., Tang X.: Phospholipase D:molecular and cell biology of a novel gene family. Biochem. J., 2000;345: 401-415
Google Scholar - 46. Liscovitch M., Czarny M., Fiucci G., Tang X.: Phospholipase D:molecular and cell biology of a novel gene family. Biochem. J., 2000;345: 401-415
Google Scholar - 47. Lisowska B., Rell-Bakalarska M., Rutkowska-Sak L.: Niesteroidoweleki przeciwzapalne – blaski i cienie. Reumatologia, 2006;44: 106-111
Google Scholar - 47. Lisowska B., Rell-Bakalarska M., Rutkowska-Sak L.: Niesteroidoweleki przeciwzapalne – blaski i cienie. Reumatologia, 2006;44: 106-111
Google Scholar - 48. Liu J., Ma D.W.: The role of n-3 polyunsaturated fatty acids inthe prevention and treatment of breast cancer. Nutrients, 2014; 6:5184-5223
Google Scholar - 48. Liu J., Ma D.W.: The role of n-3 polyunsaturated fatty acids inthe prevention and treatment of breast cancer. Nutrients, 2014; 6:5184-5223
Google Scholar - 49. Liu Y.Y., Han T.Y., Giuliano A.E., Cabot M.C.: Ceramide glycosylationpotentiates cellular multidrug resistance. FASEB J., 2001;15: 719-730
Google Scholar - 49. Liu Y.Y., Han T.Y., Giuliano A.E., Cabot M.C.: Ceramide glycosylationpotentiates cellular multidrug resistance. FASEB J., 2001;15: 719-730
Google Scholar - 50. Małyszko J., Michałkiewicz S.: Substancje biologicznie aktywnew olejach jadalnych. Wiad. Chem., 2010; 64: 467-491
Google Scholar - 50. Małyszko J., Michałkiewicz S.: Substancje biologicznie aktywnew olejach jadalnych. Wiad. Chem., 2010; 64: 467-491
Google Scholar - 51. Manna S., Chakraborty T., Ghosh B., Chatterjee M., Panda A.,Srivastava S., Rana A., Chatterjee M.: Dietary fish oil associated withincreased apoptosis and modulated expression of Bax and Bcl-2during 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesisin rats. Prostaglandins Leukot. Essent. Fatty Acids, 2008;79: 5-14
Google Scholar - 51. Manna S., Chakraborty T., Ghosh B., Chatterjee M., Panda A.,Srivastava S., Rana A., Chatterjee M.: Dietary fish oil associated withincreased apoptosis and modulated expression of Bax and Bcl-2during 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesisin rats. Prostaglandins Leukot. Essent. Fatty Acids, 2008;79: 5-14
Google Scholar - 52. Modrak D.E., Gold D.V., Goldenberg D.M.: Sphingolipid targetsin cancer therapy. Mol. Cancer Ther., 2006; 5: 200-208
Google Scholar - 52. Modrak D.E., Gold D.V., Goldenberg D.M.: Sphingolipid targetsin cancer therapy. Mol. Cancer Ther., 2006; 5: 200-208
Google Scholar - 53. Modrak D.E., Leon E., Goldenberg D.M., Gold D.V.: Ceramideregulates gemcitabine-induced senescence and apoptosis in humanpancreatic cancer cell lines. Mol. Cancer Res., 2009; 7: 890-896
Google Scholar - 53. Modrak D.E., Leon E., Goldenberg D.M., Gold D.V.: Ceramideregulates gemcitabine-induced senescence and apoptosis in humanpancreatic cancer cell lines. Mol. Cancer Res., 2009; 7: 890-896
Google Scholar - 54. Molendi-Coste O., Legry V., Leclercq I.A.: Why and how meetn-3 PUFA dietary recommendations? Gastroent. Res. Pract., 2011;2011: 364040
Google Scholar - 54. Molendi-Coste O., Legry V., Leclercq I.A.: Why and how meetn-3 PUFA dietary recommendations? Gastroent. Res. Pract., 2011;2011: 364040
Google Scholar - 55. Mollinedo F., Gajate C.: Fas/CD95 death receptor and lipid rafts:new targets for apoptosis-directed cancer therapy. Drug Resist. Updat.,2006; 9: 51-73
Google Scholar - 55. Mollinedo F., Gajate C.: Fas/CD95 death receptor and lipid rafts:new targets for apoptosis-directed cancer therapy. Drug Resist. Updat.,2006; 9: 51-73
Google Scholar - 56. Müller H., Grande T., Ahlstrøm Ø., Skrede A.: A diet rich in phosphatidylethanolamineincreases plasma homocysteine in mink:a comparison with a soyabean oil diet. Br. J. Nutr., 2005; 94: 684-690
Google Scholar - 56. Müller H., Grande T., Ahlstrøm Ø., Skrede A.: A diet rich in phosphatidylethanolamineincreases plasma homocysteine in mink:a comparison with a soyabean oil diet. Br. J. Nutr., 2005; 94: 684-690
Google Scholar - 57. Nagan N., Zoeller r.A.: Plasmalogens: biosynthesis and functions.Prog. Lipid Res., 2001; 40: 199-229
Google Scholar - 57. Nagan N., Zoeller r.A.: Plasmalogens: biosynthesis and functions.Prog. Lipid Res., 2001; 40: 199-229
Google Scholar - 58. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J.,Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., KamranpourN., Berliner J.A., Lusis A.J., Fogelman A.M.: The oxidationhypothesis of atherogenesis: the role of oxidized phospholipids andHDL. J. Lipid Res., 2004; 45: 993-1007
Google Scholar - 58. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J.,Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., KamranpourN., Berliner J.A., Lusis A.J., Fogelman A.M.: The oxidationhypothesis of atherogenesis: the role of oxidized phospholipids andHDL. J. Lipid Res., 2004; 45: 993-1007
Google Scholar - 59. Navab M., Hama S., Hough G., Fogelman A.M.: Oral syntheticphospholipid (DMPC) raises high-density lipoprotein cholesterollevels, improves high-density lipoprotein function, and markedlyreduces atherosclerosis in apolipoprotein E-null mice. Circulation,2003; 108: 1735-1739
Google Scholar - 59. Navab M., Hama S., Hough G., Fogelman A.M.: Oral syntheticphospholipid (DMPC) raises high-density lipoprotein cholesterollevels, improves high-density lipoprotein function, and markedlyreduces atherosclerosis in apolipoprotein E-null mice. Circulation,2003; 108: 1735-1739
Google Scholar - 60. Navder K.P., Baraona E., Lieber C.S.: Polyenylphosphatidylcholineattenuates alcohol-induced fatty liver and hyperlipemia in rats.J. Nutr., 1997; 127: 1800-1806
Google Scholar - 60. Navder K.P., Baraona E., Lieber C.S.: Polyenylphosphatidylcholineattenuates alcohol-induced fatty liver and hyperlipemia in rats.J. Nutr., 1997; 127: 1800-1806
Google Scholar - 61. Ninger L.J.: Homocysteine as a risk factor for disease. http://www.lifeextension.com/Magazine/2006/10/report_risk/Page-01(18.07.2015)
Google Scholar - 61. Ninger L.J.: Homocysteine as a risk factor for disease. http://www.lifeextension.com/Magazine/2006/10/report_risk/Page-01(18.07.2015)
Google Scholar - 62. Noga A.A., Stead L.M., Zhao Y., Brosnan M.E., Brosnan J.T., VanceD.E.: Plasma homocysteine is regulated by phospholipid methylation.J. Biol. Chem., 2003; 278: 5952-5955
Google Scholar - 62. Noga A.A., Stead L.M., Zhao Y., Brosnan M.E., Brosnan J.T., VanceD.E.: Plasma homocysteine is regulated by phospholipid methylation.J. Biol. Chem., 2003; 278: 5952-5955
Google Scholar - 63. Noh S.K., Koo S.I.: Egg sphingomyelin lowers the lymphaticabsorption of cholesterol and α-tocopherol in rats. J. Nutr., 2003;133: 3571-3576
Google Scholar - 63. Noh S.K., Koo S.I.: Egg sphingomyelin lowers the lymphaticabsorption of cholesterol and α-tocopherol in rats. J. Nutr., 2003;133: 3571-3576
Google Scholar - 64. Noh S.K., Koo S.I.: Milk sphingomyelin is more effective thanegg sphingomyelin in inhibiting intestinal absorption of cholesteroland fat in rats. J. Nutr., 2004; 134: 2611-2616
Google Scholar - 64. Noh S.K., Koo S.I.: Milk sphingomyelin is more effective thanegg sphingomyelin in inhibiting intestinal absorption of cholesteroland fat in rats. J. Nutr., 2004; 134: 2611-2616
Google Scholar - 65. Ogretmen B., Hannun Y.A.: Biologically active sphingolipidsin cancer pathogenesis and treatment. Nat. Rev. Cancer, 2004; 4:604-616
Google Scholar - 65. Ogretmen B., Hannun Y.A.: Biologically active sphingolipidsin cancer pathogenesis and treatment. Nat. Rev. Cancer, 2004; 4:604-616
Google Scholar - 66. Ohlsson L., Burling H., Nilsson A.: Long term effects on humanplasma lipoproteins of a formulation enriched in butter milk polarlipid. Lipids Health Dis., 2009; 8: 1-12
Google Scholar - 66. Ohlsson L., Burling H., Nilsson A.: Long term effects on humanplasma lipoproteins of a formulation enriched in butter milk polarlipid. Lipids Health Dis., 2009; 8: 1-12
Google Scholar - 67. Olthof M.R., Brink E.J., Katan M.B., Verhoef P.: Choline supplementedas phosphatidylcholine decreases fasting and postmethionine-loadingplasma homocysteine concentrations in healthy men.Am. J. Clin. Nutr., 2005; 82: 111-117
Google Scholar - 67. Olthof M.R., Brink E.J., Katan M.B., Verhoef P.: Choline supplementedas phosphatidylcholine decreases fasting and postmethionine-loadingplasma homocysteine concentrations in healthy men.Am. J. Clin. Nutr., 2005; 82: 111-117
Google Scholar - 68. Payne S.G., Milstien S., Spiegel S.: Sphingosine-1-phosphate:dual messenger functions. FEBS Lett., 2002; 531: 54-57
Google Scholar - 68. Payne S.G., Milstien S., Spiegel S.: Sphingosine-1-phosphate:dual messenger functions. FEBS Lett., 2002; 531: 54-57
Google Scholar - 69. Pepeu G., Pepeu I.M., Amaducci L.: A review of phosphatidylserinepharmacological and clinical effects. Is phosphatidylserinea drug for the ageing brain? Pharmacol. Res. 1996; 33: 73-80
Google Scholar - 69. Pepeu G., Pepeu I.M., Amaducci L.: A review of phosphatidylserinepharmacological and clinical effects. Is phosphatidylserinea drug for the ageing brain? Pharmacol. Res. 1996; 33: 73-80
Google Scholar - 70. Prentice K.J., Luu L., Allister E.M., Liu Y., Jun L.S., Sloop K.W.,Hardy A.B., Wei L., Jia W., Fantus I.G., Sweet D.H., Sweeney G., Retnakaranr., Dai F.F., Wheeler M.B.: The furan fatty acid metaboliteCMPF is elevated in diabetes and induces β cell dysfunction. CellMetab., 2014; 19: 653-666
Google Scholar - 70. Prentice K.J., Luu L., Allister E.M., Liu Y., Jun L.S., Sloop K.W.,Hardy A.B., Wei L., Jia W., Fantus I.G., Sweet D.H., Sweeney G., Retnakaranr., Dai F.F., Wheeler M.B.: The furan fatty acid metaboliteCMPF is elevated in diabetes and induces β cell dysfunction. CellMetab., 2014; 19: 653-666
Google Scholar - 71. Raisova M., Hossini A.M., Eberle J., Riebeling C., Wieder T., SturmI., Daniel P.T., Orfanos C.E., Geilen C.C.: The Bax/Bcl-2 ratio determinesthe susceptibility of human melanoma cells to CD95/Fas-mediatedapoptosis. J. Invest. Dermatol., 2001; 117: 333-340
Google Scholar - 71. Raisova M., Hossini A.M., Eberle J., Riebeling C., Wieder T., SturmI., Daniel P.T., Orfanos C.E., Geilen C.C.: The Bax/Bcl-2 ratio determinesthe susceptibility of human melanoma cells to CD95/Fas-mediatedapoptosis. J. Invest. Dermatol., 2001; 117: 333-340
Google Scholar - 72. Richter Y., Herzog Y., Cohen T., Steinhart Y.: The effect of phosphatidylserine-containingomega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study. Clin.Interv. Aging, 2010; 5: 313-316
Google Scholar - 72. Richter Y., Herzog Y., Cohen T., Steinhart Y.: The effect of phosphatidylserine-containingomega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study. Clin.Interv. Aging, 2010; 5: 313-316
Google Scholar - 73. Richter Y., Herzog Y., Lifshitz Y., Hayun r., Zchut S.: The effectof soybean-derived phosphatidylserine on cognitive performancein elderly with subjective memory complaints: a pilot study. Clin.Interv. Aging, 2013; 8: 557-563
Google Scholar - 73. Richter Y., Herzog Y., Lifshitz Y., Hayun r., Zchut S.: The effectof soybean-derived phosphatidylserine on cognitive performancein elderly with subjective memory complaints: a pilot study. Clin.Interv. Aging, 2013; 8: 557-563
Google Scholar - 74. Rivnay B., Orbital-Harel T., Shinitzky M., Globerson A.: Enhancementof the response of ageing mouse lymphocytes by in vitro treatmentwith lecithin. Mech. Ageing Dev., 1983; 23: 329-336
Google Scholar - 74. Rivnay B., Orbital-Harel T., Shinitzky M., Globerson A.: Enhancementof the response of ageing mouse lymphocytes by in vitro treatmentwith lecithin. Mech. Ageing Dev., 1983; 23: 329-336
Google Scholar - 75. Ross B.M., Seguin J., Sieswerda L.E.: Omega-3 fatty acids as treatmentsfor mental illness: which disorder and which fatty acid? LipidsHealth Dis., 2007; 6: 21
Google Scholar - 75. Ross B.M., Seguin J., Sieswerda L.E.: Omega-3 fatty acids as treatmentsfor mental illness: which disorder and which fatty acid? LipidsHealth Dis., 2007; 6: 21
Google Scholar - 76. Roynette C.E., Calder P.C., Dupertuis Y.M., Pichard C.: n-3 polyunsaturatedfatty acids and colon cancer prevention. Clin. Nutr.,2004; 23: 139-151
Google Scholar - 76. Roynette C.E., Calder P.C., Dupertuis Y.M., Pichard C.: n-3 polyunsaturatedfatty acids and colon cancer prevention. Clin. Nutr.,2004; 23: 139-151
Google Scholar - 77. Sadurska B., Szumiło M.: Fosfolipazy A w komórkach ssaków –budowa, właściwości, rola fizjologiczna i patologiczna. Postępy Hig.Med. Dośw., 2005; 59: 116-123
Google Scholar - 77. Sadurska B., Szumiło M.: Fosfolipazy A w komórkach ssaków –budowa, właściwości, rola fizjologiczna i patologiczna. Postępy Hig.Med. Dośw., 2005; 59: 116-123
Google Scholar - 78. Schley P.D., Brindley D.N., Field C.J.: (n-3) PUFA alter raft lipidcomposition and decrease epidermal growth factor receptor levelsin lipid rafts of human breast cancer cells. J. Nutr., 2007; 137: 548-553
Google Scholar - 78. Schley P.D., Brindley D.N., Field C.J.: (n-3) PUFA alter raft lipidcomposition and decrease epidermal growth factor receptor levelsin lipid rafts of human breast cancer cells. J. Nutr., 2007; 137: 548-553
Google Scholar - 79. Schubert M., Contreras C., Franz N., Hellhammer J.: Milk-basedphospholipids increase morning cortisol availability and improvememory in chronically stressed men. Nutr. Res., 2011; 31: 413-420
Google Scholar - 79. Schubert M., Contreras C., Franz N., Hellhammer J.: Milk-basedphospholipids increase morning cortisol availability and improvememory in chronically stressed men. Nutr. Res., 2011; 31: 413-420
Google Scholar - 80. Shirouchi B., Nagao K., Inoue N., Furuya K., Koga S., MatsumotoH., Yanagita T.: Dietary phosphatidylinositol prevents the developmentof nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J.Agric. Food Chem., 2008; 56: 2375-2379
Google Scholar - 80. Shirouchi B., Nagao K., Inoue N., Furuya K., Koga S., MatsumotoH., Yanagita T.: Dietary phosphatidylinositol prevents the developmentof nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J.Agric. Food Chem., 2008; 56: 2375-2379
Google Scholar - 81. Siró I., Kápolna E., Kápolna B., Lugasi A.: Functional food. Productdevelopment, marketing and consumer acceptance – a review.Appetite, 2008; 51: 456-467
Google Scholar - 81. Siró I., Kápolna E., Kápolna B., Lugasi A.: Functional food. Productdevelopment, marketing and consumer acceptance – a review.Appetite, 2008; 51: 456-467
Google Scholar - 82. Spiteller G.: Furan fatty acids: occurrence, synthesis, and reactions.Are furan fatty acids responsible for the cardioprotective effectsof a fish diet? Lipids, 2005; 40: 755-771
Google Scholar - 82. Spiteller G.: Furan fatty acids: occurrence, synthesis, and reactions.Are furan fatty acids responsible for the cardioprotective effectsof a fish diet? Lipids, 2005; 40: 755-771
Google Scholar - 83. Steenge G.R., Verhoef P., Katan M.B.: Betaine supplementationlowers plasma homocysteine in healthy men and women. J. Nutr.,2003; 133: 1291-1295
Google Scholar - 83. Steenge G.R., Verhoef P., Katan M.B.: Betaine supplementationlowers plasma homocysteine in healthy men and women. J. Nutr.,2003; 133: 1291-1295
Google Scholar - 84. Swanson D., Block r., Mousa S.A.: Omega-3 fatty acids EPA andDHA: health benefits throughout life. Adv. Nutr., 2012; 3: 1-7
Google Scholar - 84. Swanson D., Block r., Mousa S.A.: Omega-3 fatty acids EPA andDHA: health benefits throughout life. Adv. Nutr., 2012; 3: 1-7
Google Scholar - 85. Szumiło M., Rahden-Staroń I.: Fosfolipaza D w komórkach ssaków– budowa, właściwości, rola fizjologiczna i patologiczna. PostępyHig. Med. Dośw., 2006; 60: 421-430
Google Scholar - 85. Szumiło M., Rahden-Staroń I.: Fosfolipaza D w komórkach ssaków– budowa, właściwości, rola fizjologiczna i patologiczna. PostępyHig. Med. Dośw., 2006; 60: 421-430
Google Scholar - 86. Tanaka T., Kassai A., Ohmoto M., Morito K., Kashiwada Y.,Takaishi Y., Urikura M., Morishige J., Satouchi K., Tokumura A.:Quantification of phosphatidic acid in foodstuffs using a thinlayer-chromatography-imagingtechnique. J. Agric. Food Chem.,2012; 60: 4156-4161
Google Scholar - 86. Tanaka T., Kassai A., Ohmoto M., Morito K., Kashiwada Y.,Takaishi Y., Urikura M., Morishige J., Satouchi K., Tokumura A.:Quantification of phosphatidic acid in foodstuffs using a thinlayer-chromatography-imagingtechnique. J. Agric. Food Chem.,2012; 60: 4156-4161
Google Scholar - 87. Taylor L.A., Pletschen L., Arends J., Unger C., Massing U.: Marinephospholipids – a promising new dietary approach to tumor-associatedweight loss. Support. Care Cancer, 2010; 18: 159-170
Google Scholar - 87. Taylor L.A., Pletschen L., Arends J., Unger C., Massing U.: Marinephospholipids – a promising new dietary approach to tumor-associatedweight loss. Support. Care Cancer, 2010; 18: 159-170
Google Scholar - 88. Tokumura A.: Physiological significance of lysophospholipidsthat act on the lumen side of mammalian lower digestive tracts. J.Health Sci., 2011; 57: 115-128
Google Scholar - 88. Tokumura A.: Physiological significance of lysophospholipidsthat act on the lumen side of mammalian lower digestive tracts. J.Health Sci., 2011; 57: 115-128
Google Scholar - 89. Vance J.E., Steenbergen r.: Metabolism and functions of phosphatidylserine.Prog. Lipid Res., 2005; 44: 207-234
Google Scholar - 89. Vance J.E., Steenbergen r.: Metabolism and functions of phosphatidylserine.Prog. Lipid Res., 2005; 44: 207-234
Google Scholar - 90. Vannice G., Rasmussen H.: Position of the academy of nutritionand dietetics: dietary fatty acids for healthy adults. J. Acad. Nutr.Diet., 2014; 114: 136-153
Google Scholar - 90. Vannice G., Rasmussen H.: Position of the academy of nutritionand dietetics: dietary fatty acids for healthy adults. J. Acad. Nutr.Diet., 2014; 114: 136-153
Google Scholar - 91. Vetter W., Wendlinger C.: Furan fatty acids – valuable minorfatty acids in food. Lipid Tech., 2013; 25: 7-10
Google Scholar - 91. Vetter W., Wendlinger C.: Furan fatty acids – valuable minorfatty acids in food. Lipid Tech., 2013; 25: 7-10
Google Scholar - 92. Wakimoto T., Kondo H., Nii H., Kimura K., Egami Y., Oka Y., YoshidaM., Kida E., Ye Y., Akahoshi S., Asakawa T., Matsumura K., IshidaH., Nukaya H., Tsuji K., Kan T., Abe I.: Furan fatty acid as an antiinflammatorycomponent from the green-lipped mussel Perna canaliculus.Proc. Natl. Acad. Sci. USA, 2011; 108: 17533-17537
Google Scholar - 92. Wakimoto T., Kondo H., Nii H., Kimura K., Egami Y., Oka Y., YoshidaM., Kida E., Ye Y., Akahoshi S., Asakawa T., Matsumura K., IshidaH., Nukaya H., Tsuji K., Kan T., Abe I.: Furan fatty acid as an antiinflammatorycomponent from the green-lipped mussel Perna canaliculus.Proc. Natl. Acad. Sci. USA, 2011; 108: 17533-17537
Google Scholar - 93. Wang G., Ryu S., Wang X.: Plant phospholipases: an overview.Methods Mol. Biol., 2012; 861: 123-137
Google Scholar - 93. Wang G., Ryu S., Wang X.: Plant phospholipases: an overview.Methods Mol. Biol., 2012; 861: 123-137
Google Scholar - 94. Wang Z., Klipfel E., Bennett B.J., Koeth r., Levison B.S., DuGar B.,Feldstein A.E., Britt E.B., Fu X., Chung Y.M., Wu Y., Schauer P., SmithJ.D., Allayee H., Tang W.H., DiDonato J.A., Lusis A.J., Hazen S.L.: Gutflora metabolism of phosphatidylcholine promotes cardiovasculardisease. Nature, 2011; 472: 57-63
Google Scholar - 94. Wang Z., Klipfel E., Bennett B.J., Koeth r., Levison B.S., DuGar B.,Feldstein A.E., Britt E.B., Fu X., Chung Y.M., Wu Y., Schauer P., SmithJ.D., Allayee H., Tang W.H., DiDonato J.A., Lusis A.J., Hazen S.L.: Gutflora metabolism of phosphatidylcholine promotes cardiovasculardisease. Nature, 2011; 472: 57-63
Google Scholar - 95. Watson A.D.: Thematic review series: systems biology approachesto metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J. Lipid Res., 2006; 47: 2101-2111
Google Scholar - 95. Watson A.D.: Thematic review series: systems biology approachesto metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J. Lipid Res., 2006; 47: 2101-2111
Google Scholar - 96. Wheeldon L.W.: Composition of cabbage leaf phospholipids. J.Lipid Res., 1960; 1: 439-445
Google Scholar - 96. Wheeldon L.W.: Composition of cabbage leaf phospholipids. J.Lipid Res., 1960; 1: 439-445
Google Scholar - 97. Wojtukiewicz M.Z., Sierko E., Szambora P.: Patofizjologicznepodstawy terapii ukierunkowanej na zahamowanie funkcji receptoraczynnika wzrostu naskórka (EGFR). Onkol. Prakt. Klin., 2010;6: 217-227
Google Scholar - 97. Wojtukiewicz M.Z., Sierko E., Szambora P.: Patofizjologicznepodstawy terapii ukierunkowanej na zahamowanie funkcji receptoraczynnika wzrostu naskórka (EGFR). Onkol. Prakt. Klin., 2010;6: 217-227
Google Scholar - 98. Yaqoob M., Nabi A., Masoom-Yasinzai M.: Bioconversion of phosphatidylcholineto phosphatidylserine using immobilized enzymemini-columns. Process Biochem., 2001; 36: 1181-1185
Google Scholar - 98. Yaqoob M., Nabi A., Masoom-Yasinzai M.: Bioconversion of phosphatidylcholineto phosphatidylserine using immobilized enzymemini-columns. Process Biochem., 2001; 36: 1181-1185
Google Scholar